AIRS Stock: AirSculpt Technologies, Inc. Stock Price, Analysis & Insights
Get live airs stock price $3.96, comprehensive AirSculpt Technologies, Inc. stock analysis, charts, news, and expert forecast. Real-time airs stock data and investment insights.
Loading chart...
Company Overview
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Company Information
- CEO
- Yogesh Jashnani
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 389
Contact Information
- Address
- 400 Alton Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.61)
Business Model & Strategy
AirSculpt Technologies, Inc. operates in the Medical - Care Facilities industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Yogesh Jashnani, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Care Facilities model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
AirSculpt Technologies, Inc. competes in the Medical - Care Facilities within the broader Healthcare. With 247.2 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, AirSculpt Technologies, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating AirSculpt Technologies, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for AirSculpt Technologies, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for AirSculpt Technologies, Inc.
- ⚠Investors should consider how AirSculpt Technologies, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
247.25M
P/E Ratio
-13.20
Beta
2.61
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 247.25M market capitalization
- Trading Volume: 668.93K shares traded today
- Price Range: 52-week range of $1.53 - $12.00
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for AirSculpt Technologies, Inc.
AirSculpt Technologies, Inc. (AIRS) operates in the Medical - Care Facilities industry within the Healthcare sector. With a current market capitalization of 247.25M, the company represents a significant player in its market. The stock is currently trading at $3.96 with a negativedaily change of 5.04%.
The company's 389 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -13.20, beta of 2.61, and 52-week price range from $1.53 to $12.00when evaluating investment opportunities.
Why Invest in AirSculpt Technologies, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Yogesh Jashnani
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.